These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 32701580)
1. Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV. Trunfio M; Rugge W; Mighetto L; Vai D; Atzori C; Nigra M; Domini S; Borgogno E; Guastamacchia G; Bonora S; Di Perri G; Calcagno A AIDS; 2020 Nov; 34(13):1899-1906. PubMed ID: 32701580 [TBL] [Abstract][Full Text] [Related]
2. Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study. Livelli A; Vaida F; Ellis RJ; Ma Q; Ferrara M; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; McCutchan JA; Morgello S; Sacktor N; Simpson DM; Grant I; Letendre SL; Lancet HIV; 2019 Jul; 6(7):e456-e462. PubMed ID: 31208949 [TBL] [Abstract][Full Text] [Related]
4. Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish EARTH-2 Study. Early Anti-Retroviral Therapy Study. García F; Alonso MM; Romeu J; Knobel H; Arrizabalaga J; Ferrer E; Dalmau D; Ruiz I; Vidal F; Frances A; Segura F; Gomez-Sirvent JL; Cruceta A; Clotet B; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM J Acquir Immune Defic Syndr; 2000 Sep; 25(1):26-35. PubMed ID: 11064501 [TBL] [Abstract][Full Text] [Related]
5. Discordant CSF/plasma HIV-1 RNA in individuals on virologically suppressive antiretroviral therapy in Western India. Dravid AN; Natrajan K; Kulkarni MM; Saraf CK; Mahajan US; Kore SD; Rathod NM; Mahajan US; Wadia RS Medicine (Baltimore); 2018 Feb; 97(8):e9969. PubMed ID: 29465595 [TBL] [Abstract][Full Text] [Related]
6. HIV-1 replication in central nervous system increases over time on only protease inhibitor therapy. Donath M; Wolf T; Stürmer M; Herrmann E; Bickel M; Khaykin P; Göpel S; Gute P; Haberl A; de Leuw P; Schüttfort G; Berger A; Stephan C; Med Microbiol Immunol; 2016 Dec; 205(6):575-583. PubMed ID: 27469377 [TBL] [Abstract][Full Text] [Related]
7. Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults. Mukerji SS; Misra V; Lorenz D; Cervantes-Arslanian AM; Lyons J; Chalkias S; Wurcel A; Burke D; Venna N; Morgello S; Koralnik IJ; Gabuzda D J Acquir Immune Defic Syndr; 2017 Jun; 75(2):246-255. PubMed ID: 28328546 [TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid viral load and neopterin in HIV-positive patients with undetectable viraemia. Motta I; Allice T; Romito A; Ferrara M; Ecclesia S; Imperiale D; Ghisetti V; Di Perri G; Bonora S; Calcagno A Antivir Ther; 2017; 22(6):539-543. PubMed ID: 28198350 [TBL] [Abstract][Full Text] [Related]
9. Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy. Anderson AM; Muñoz-Moreno JA; McClernon DR; Ellis RJ; Cookson D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; McCutchan JA; Morgello S; Sacktor N; Simpson DM; Franklin DR; Heaton RK; Grant I; Letendre SL; J Infect Dis; 2017 Jan; 215(1):105-113. PubMed ID: 27789723 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of cerebrospinal fluid virological escape in patients on long-term protease inhibitor monotherapy. Arenas-Pinto A; Stöhr W; Clarke A; Williams I; Beeching NJ; Minton J; Lee V; Paton NI; Antivir Ther; 2017; 22(6):535-538. PubMed ID: 28234235 [TBL] [Abstract][Full Text] [Related]
11. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Canestri A; Lescure FX; Jaureguiberry S; Moulignier A; Amiel C; Marcelin AG; Peytavin G; Tubiana R; Pialoux G; Katlama C Clin Infect Dis; 2010 Mar; 50(5):773-8. PubMed ID: 20100092 [TBL] [Abstract][Full Text] [Related]
12. Relapse of Symptomatic Cerebrospinal Fluid HIV Escape. Ferretti F; De Zan V; Gerevini S; Turrini F; Boeri E; Gianotti N; Hasson H; Lazzarin A; Cinque P Curr HIV/AIDS Rep; 2020 Oct; 17(5):522-528. PubMed ID: 32875516 [TBL] [Abstract][Full Text] [Related]
13. Impact of Antiretroviral Regimens on Cerebrospinal Fluid Viral Escape in a Prospective Multicohort Study of Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-1-Infected Adults in the United States. Mukerji SS; Misra V; Lorenz DR; Uno H; Morgello S; Franklin D; Ellis RJ; Letendre S; Gabuzda D Clin Infect Dis; 2018 Sep; 67(8):1182-1190. PubMed ID: 29617912 [TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study. Filippidis P; Damas J; Viala B; Assal F; Nawej Tshikung O; Tarr P; Derfuss T; Oberholzer M; Jelcic I; Hundsberger T; Sacco L; Cavassini M; Du Pasquier R; Darling KEA; J Acquir Immune Defic Syndr; 2023 Jul; 93(3):219-228. PubMed ID: 36927958 [TBL] [Abstract][Full Text] [Related]
15. Presence of Epstein-Barr virus DNA in cerebrospinal fluid is associated with greater HIV RNA and inflammation. Lupia T; Milia MG; Atzori C; Gianella S; Audagnotto S; Imperiale D; Mighetto L; Pirriatore V; Gregori G; Lipani F; Ghisetti V; Bonora S; Di Perri G; Calcagno A AIDS; 2020 Mar; 34(3):373-380. PubMed ID: 31764071 [TBL] [Abstract][Full Text] [Related]
16. Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid. Cinque P; Presi S; Bestetti A; Pierotti C; Racca S; Boeri E; Morelli P; Carrera P; Ferrari M; Lazzarin A AIDS Res Hum Retroviruses; 2001 Mar; 17(5):377-83. PubMed ID: 11282006 [TBL] [Abstract][Full Text] [Related]
17. Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia. Nightingale S; Geretti AM; Beloukas A; Fisher M; Winston A; Else L; Nelson M; Taylor S; Ustianowski A; Ainsworth J; Gilson R; Haddow L; Ong E; Watson V; Leen C; Minton J; Post F; Pirmohamed M; Solomon T; Khoo S J Neurovirol; 2016 Dec; 22(6):852-860. PubMed ID: 27194435 [TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid HIV RNA in persons living with HIV. Di Carlofelice M; Everitt A; Muir D; Winston A HIV Med; 2018 May; 19(5):365-368. PubMed ID: 29368400 [TBL] [Abstract][Full Text] [Related]
19. Diffuse White Matter Signal Abnormalities on Magnetic Resonance Imaging Are Associated With Human Immunodeficiency Virus Type 1 Viral Escape in the Central Nervous System Among Patients With Neurological Symptoms. Kugathasan R; Collier DA; Haddow LJ; El Bouzidi K; Edwards SG; Cartledge JD; Miller RF; Gupta RK Clin Infect Dis; 2017 Apr; 64(8):1059-1065. PubMed ID: 28329096 [TBL] [Abstract][Full Text] [Related]
20. CSF Inflammation Markers Associated with Asymptomatic Viral Escape in Cerebrospinal Fluid of HIV-Positive Individuals on Antiretroviral Therapy. Guha D; Misra V; Yin J; Gabuzda D Viruses; 2023 Aug; 15(9):. PubMed ID: 37766236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]